earlier month i posted article crispr asked would answer waiting kennedy disease rare disease communities opportunity human gene editing generated lot interest questions concerning use two comments concerning potential breakthrough may national academy sciences national academy medicine announce initiative human gene editing joint statement ralph cicerone victor dzau washington national academy sciences national academy medicine launching major initiative guide decision making controversial new research involving human gene editing human gene editing technologies crispr cas may lead promising new treatments disease however recent experiments attempt edit human genes also raised important questions potential risks ethical concerns altering human germline future advances likely raise new questions initiative include international summit fall convene researchers experts explore scientific ethical policy issues associated human gene editing research addition appoint multidisciplinary international committee begin comprehensive study scientific underpinnings clinical ethical legal social implications human gene editing committee consider recommend standards guidelines practices governing use gene editing technologies biomedical research medicine advisory group steer overall initiative soon announced provided leadership past emerging controversial new areas genetic research human embryonic stem cell research human cloning gain function research asilomar conference convened national academy sciences led guidelines recombinant dna research keeping past efforts prepared work scientific medical communities achieve comprehensive understanding human gene editing implications order help guide researchers clinicians policy makers public around world ralph cicerone president national academy sciences private nonprofit institution provides science policy advice nation congressional charter victor dzau president institute medicine founded health arm nas effective july iom become national academy medicine dzau first president statement nih funding research using gene editing technologies human embryos april genomic editing area research seeking modify genes living organisms improve understanding gene function advance potential therapeutic applications correct genetic abnormalities researchers china recently described experiments nonviable human embryo modify gene responsible potentially fatal blood disorder using gene editing technology called crispr cas crispr cas customizable tool lets scientists cut insert small pieces dna precise areas along dna strand tool composed two basic parts cas protein acts like wrench specific rna guides crisprs set different socket heads guides direct cas protein correct gene area dna strand controls particular trait lets scientists study genes specific targeted way real time genomic editing already widely studied variety organisms example crispr cas greatly shortened time takes produce knockout mouse models disease enabling researchers study easily underlying genetic causes diseases technology also used develop next generation antimicrobials specifically target harmful strains bacteria viruses first clinical application genomic editing related genome editing technique using zinc finger nuclease used create hiv resistance human immune cells bringing hiv viral load undetectable levels least one individual examples research using genomic editing technologies funded nih however nih fund use gene editing technologies human embryos concept altering human germline embryos clinical purposes debated many years many different perspectives viewed almost universally line crossed advances technology given elegant new way carrying genome editing strong arguments engaging activity remain include serious unquantifiable safety issues ethical issues presented altering germline way affects next generation without consent current lack compelling medical applications justifying use crispr cas embryos practically multiple existing legislative regulatory prohibitions kind work dickey wicker amendment prohibits use appropriated funds creation human embryos research purposes research human embryos destroyed r furthermore nih guidelines state recombinant dna advisory committee present entertain proposals germ line alteration also important note role food drug administration fda arena applies federally funded research research public health service federal food drug cosmetic give fda authority regulate cell gene therapy products biological products drugs would include oversight human germline modification development biological products may used humans investigational new drug application effect cfr part nih continue support wide range innovations biomedical research fashion reflects well established scientific ethical principles francis collins ph director national institutes health